Trademark: 79107529
Word
NANO BIOTIX
Status Date
Tuesday, November 9, 2021
Registration Number
4266230
Registration Date
Tuesday, January 1, 2013
Filing Date
Wednesday, November 9, 2011
Published for Opposition
Tuesday, October 16, 2012
Cancellation Date
Tuesday, November 9, 2021
5 Preparations for medical use particularly for the diagnosis and treatment of tumors; preparations for medical use particularly for the diagnosis and treatment of tumors using radiation treatment; radioactive substances for medical use for the diagnosis and treatment of tumors using radiation treatment; radiological contrast substances for medical use; chemical reagents for medical use; bacteriological preparations for medical use; enzymes for medical use; enzyme preparations for medical use; diagnostic preparations for medical use; antibiotics; antiseptics; health care preparations for treating cancer; biological preparations for medical use for the treatment of cancer; chemical preparations for medical or pharmaceutical use particularly for use in treating cancer; drugs for medical use for use in the treatment of cancer; medicines for human purposes for use in the treatment of cancer; restorative medicine for use in the treatment of oncological diseases; chemical-pharmaceutical preparations for use in treating oncological disease and disorders; pharmaceutical preparations for use in treating oncological disease and disorders
44 Health services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs; medical services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs
10 [ Apparatus for use in medical analysis, namely, medical X-ray apparatus, diagnostic apparatus for medical use, namely, medical X-ray apparatus; radiology screens for medical use; X-ray photographs for medical purposes; medical X-ray apparatus and installations, namely, mounts for the production of X-rays, for medical use; X-ray protection devices for medical use, namely, radiology screens; special furniture for medical use, namely, therapeutic mattresses, beds, seats and cushions ]
42 Scientific and technological services, namely, research and design services in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications for use in nanomedicine which is nanotechnology applied to medicine; scientific and technological evaluations, estimates and investigations provided by engineers, researchers in the field of nanomedicine; technical project studies, namely, technical research in the field of nanomedicine; industrial analysis and research services in the field of nanomedicine; chemistry services, namely, chemistry consultation; expert appraisals in the field of engineering, namely, consultation in the field of engineering; technical research in the field of nanomedicine
The mark consists of a depiction of a sphere with the term "NANO" contained therein and to the right of the depiction of the sphere is the term "BIOTIX".
Color is not claimed as a feature of the mark.
Jun 5, 2022
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jun 5, 2022
Death Of International Registration
Jan 1, 2022
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Jul 31, 2020
Partial Invalidation Processed By The Ib
Jun 19, 2020
Partial Invalidation Of Reg Ext Protection Sent To Ib
Jun 19, 2020
Invalidation Processed
May 20, 2020
Partial Invalidation Of Reg Ext Protection Created
Sep 20, 2019
Notice Of Acceptance Of Sec. 71 - E-Mailed
Sep 20, 2019
Registered - Partial Sec 71 Accepted
Jul 4, 2019
Teas Response To Office Action-Post Reg Received
Jan 17, 2019
Post Registration Action Mailed - Sec.71
Jan 17, 2019
Case Assigned To Post Registration Paralegal
Nov 27, 2018
Teas Section 71 Received
Jan 1, 2018
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 29, 2013
Final Decision Transaction Processed By Ib
Apr 8, 2013
Final Disposition Notice Sent To Ib
Apr 8, 2013
Final Disposition Processed
Apr 1, 2013
Final Disposition Notice Created, To Be Sent To Ib
Jan 1, 2013
Registered-Principal Register
Nov 5, 2012
Notification Processed By Ib
Oct 16, 2012
Official Gazette Publication Confirmation E-Mailed
Oct 16, 2012
Published For Opposition
Sep 26, 2012
Notification Of Possible Opposition Sent To Ib
Sep 26, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 26, 2012
Notification Of Notice Of Publication E-Mailed
Sep 7, 2012
Law Office Publication Review Completed
Sep 7, 2012
Assigned To Lie
Aug 28, 2012
Approved For Pub - Principal Register
Aug 28, 2012
Examiner's Amendment Entered
Aug 28, 2012
Notification Of Examiners Amendment E-Mailed
Aug 28, 2012
Examiners Amendment E-Mailed
Aug 28, 2012
Examiners Amendment -Written
Aug 28, 2012
Previous Allowance Count Withdrawn
Aug 27, 2012
Approved For Pub - Principal Register
Aug 27, 2012
Examiner's Amendment Entered
Aug 27, 2012
Correspondence E-Mailed
Aug 27, 2012
Examiners Amendment -Written
Aug 27, 2012
Teas/Email Correspondence Entered
Aug 27, 2012
Correspondence Received In Law Office
Aug 27, 2012
Teas Request For Reconsideration Received
Aug 17, 2012
Notification Of Final Refusal Emailed
Aug 17, 2012
Final Refusal E-Mailed
Aug 17, 2012
Final Refusal Written
Jul 26, 2012
Teas/Email Correspondence Entered
Jul 26, 2012
Correspondence Received In Law Office
Jul 26, 2012
Teas/Email Correspondence Entered
Jul 25, 2012
Correspondence Received In Law Office
Jul 26, 2012
Teas Response To Office Action Received
Jul 25, 2012
Teas Response To Office Action Received
Jul 25, 2012
Teas Change Of Correspondence Received
Mar 24, 2012
Refusal Processed By Ib
Mar 1, 2012
Non-Final Action Mailed - Refusal Sent To Ib
Mar 1, 2012
Refusal Processed By Mpu
Mar 1, 2012
Non-Final Action (Ib Refusal) Prepared For Review
Feb 29, 2012
Non-Final Action Written
Feb 27, 2012
Assigned To Examiner
Jan 17, 2012
Application Filing Receipt Mailed
Jan 13, 2012
New Application Office Supplied Data Entered In Tram
Jan 12, 2012
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
